XS228CN-derived motor neuron progenitor cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XS228CN-derived motor neuron progenitor cells, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis [Phase 1]